Sorbitol dehydrogenase (SORD; EC 1.1.1.14) catalyzes the interconversion of polyols and their corresponding ketoses, and together with aldose reductase (ALDR1; MIM 103880), makes up the sorbitol pathway that is believed to play an important role in the development of diabetic complications (summarized by Carr and Markham, 1995 [PubMed 8535074]). The first reaction of the pathway (also called the polyol pathway) is the reduction of glucose to sorbitol by ALDR1 with NADPH as the cofactor. SORD then oxidizes the sorbitol to fructose using NAD(+) cofactor.
Human Sorbitol dehydrogenase (SDH) ELISA Kit employs a two-site sandwich ELISA to quantitate SORD in samples. An antibody specific for SORD has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anySORD present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for SORD is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of SORD bound in the initial step. The color development is stopped and the intensity of the color is measured.
Human Sorbitol dehydrogenase (SDH) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.
Find more details at http://www.abbkine.com/product/human-sorbitol-dehydrogenase-sdh-elisa-kit-kte60558/
bio-equip.cn
中文
